Clinical trial
A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
NCT06268665 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
- Lead sponsor
- University of California, Davis
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 15, 2024
- Completion date
- December 31, 2027
- Enrollment
- 86 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, breast cancer invasive, breast cancer stage i, breast cancer stage ii, breast cancer stage iia, breast cancer stage iib, breast cancer stage iii, breast cancer stage iiia, breast cancer stage iiib, breast cancer stage iiic, breast cancer stage iv, breast cancer, stage ia, breast cancer, stage ib, breast carcinoma, breast neoplasm, cancer of ovary, cancer, breast, invasive breast cancer, malignant breast neoplasm, malignant tumor of breast, mammary cancer, mammary carcinoma, ovarian cancer, ovarian cancer stage 1, ovarian cancer stage 2, ovarian cancer stage 3, ovarian cancer stage ia, ovarian cancer stage ib, ovarian cancer stage ic, ovarian cancer stage ii, ovarian cancer stage iii, ovarian cancer stage iiib, ovarian cancer stage iiic, ovarian cancer stage iv, ovary cancer, ovary neoplasm, tumors, breast